Skip to main content
. 2010 Apr 28;91(6):1621–1626. doi: 10.3945/ajcn.2009.27972

TABLE 1.

Demographic characteristics of the subjects1

Characteristics Placebo (n = 15) Vitamin D3 in OJ (n = 18) Vitamin D2 in OJ (n = 17) Vitamin D3 in capsules (n = 20) Vitamin D2 in capsules (n = 16)
Age (y)
 Mean ± SD 40.8 ± 10.8 41.4 ± 12.6 40.1 ± 15.6 40.1 ± 18.0 38.9 ± 12.3
 Range 24–59 22–65 19–73 22–81 18–59
Sex [n (%)]
 Female 13 (86.7) 15 (83.3) 9 (52.9) 12 (60) 10 (62.5)
 Male 2 (13.3) 3 (16.7) 8 (47.1) 8 (40) 6 (37.5)
BMI (kg/m2) 27.8 29.9 27 29.1 30.4
Race [n (%)]
 Asian 1 (6.7) 1 (9.1) 1 (5.9) 4 (20) 1 (6.25)
 American Indian 0 (0) 0 (0) 0 (0) 0 (0) 1 (6.25)
 Black 7 (46.7) 11 (61.1) 9 (52.9) 8 (40) 9 (56.25)
 Hispanic 0 (0) 2 (11.1) 0 (0) 2 (10) 1 (6.25)
 White 6 (40) 2 (11.1) 6 (35.3) 6 (30) 4 (25)
 Other 1 (6.7) 2 (11.1) 1 (5.9) 0 (0) 0 (0)
Multivitamin use [n (%)] 5 (33.3) 5 (27.8) 6 (35.3) 4 (20) 5 (31.3)
Vitamin D supplement use (n) 0 0 0 0 0
Dropouts [n (%)] 5 (21.7) 2 (9.1) 3 (15) 0 (0) 4 (20)
Compliance (%) 95.6 95.0 94.0 95.3 94.1
1

OJ, orange juice.